A Phase I Study of AZD2281 in Combination With Irinotecan in Patients With Locally Advanced or Metastatic Incurable Colorectal Cancer.
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2016
At a glance
- Drugs Irinotecan (Primary) ; Olaparib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics
- 13 Apr 2016 Results published in the Investigational New Drugs
- 21 Sep 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 20 Jun 2013 Planned end date changed from 1 Nov 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.